AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 45 filers reported holding AEVI GENOMIC MEDICINE INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,765,000 | -43.1% | 3,950,419 | 0.0% | 0.02% | -28.1% |
| Q3 2018 | $4,859,000 | +8.0% | 3,950,419 | -2.6% | 0.03% | -5.9% |
| Q2 2018 | $4,501,000 | -44.8% | 4,055,142 | 0.0% | 0.03% | -50.7% |
| Q1 2018 | $8,151,000 | +67.5% | 4,055,142 | 0.0% | 0.07% | +64.3% |
| Q4 2017 | $4,866,000 | -15.0% | 4,055,142 | -10.8% | 0.04% | -8.7% |
| Q3 2017 | $5,728,000 | +166.2% | 4,546,426 | +181.0% | 0.05% | +142.1% |
| Q2 2017 | $2,152,000 | -28.5% | 1,618,089 | 0.0% | 0.02% | -24.0% |
| Q1 2017 | $3,010,000 | -34.0% | 1,618,089 | +83.8% | 0.02% | -44.4% |
| Q4 2016 | $4,561,000 | – | 880,539 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 155,000 | $206,000 | 0.12% |
| Birchview Capital, LP | 128,000 | $170,000 | 0.09% |
| CARL DOMINO INC | 43,273 | $58,000 | 0.07% |
| NORTHERN CAPITAL MANAGEMENT LLC | 106,050 | $141,000 | 0.05% |
| ELEMENT CAPITAL MANAGEMENT LLC | 124,423 | $165,000 | 0.03% |
| Baker Brothers Advisors | 1,618,089 | $2,152,000 | 0.02% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $32,000 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 31,390 | $42,000 | 0.02% |
| WHITE PINE CAPITAL LLC | 20,000 | $27,000 | 0.01% |
| LMR Partners LLP | 112,265 | $149,000 | 0.01% |